390 related articles for article (PubMed ID: 26232880)
1. Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation.
Huang RL; Chen G; Wang W; Herller T; Xie Y; Gu B; Li Q
Biomaterials; 2015 Oct; 67():308-22. PubMed ID: 26232880
[TBL] [Abstract][Full Text] [Related]
2. IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways.
Huang RL; Sun Y; Ho CK; Liu K; Tang QQ; Xie Y; Li Q
Cell Death Dis; 2018 Feb; 9(2):144. PubMed ID: 29396550
[TBL] [Abstract][Full Text] [Related]
3. Exaggerated inflammatory environment decreases BMP-2/ACS-induced ectopic bone mass in a rat model: implications for clinical use of BMP-2.
Huang RL; Yuan Y; Tu J; Zou GM; Li Q
Osteoarthritis Cartilage; 2014 Aug; 22(8):1186-96. PubMed ID: 24981632
[TBL] [Abstract][Full Text] [Related]
4. Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways.
Feng W; Liu H; Luo T; Liu D; Du J; Sun J; Wang W; Han X; Yang K; Guo J; Amizuka N; Li M
Sci Rep; 2017 Jan; 7():41411. PubMed ID: 28128332
[TBL] [Abstract][Full Text] [Related]
5. Strontium attenuates rhBMP-2-induced osteogenic differentiation via formation of Sr-rhBMP-2 complex and suppression of Smad-dependent signaling pathway.
Zhang W; Tian Y; He H; Chen R; Ma Y; Guo H; Yuan Y; Liu C
Acta Biomater; 2016 Mar; 33():290-300. PubMed ID: 26828127
[TBL] [Abstract][Full Text] [Related]
6. Cartilage oligomeric matrix protein enhances osteogenesis by directly binding and activating bone morphogenetic protein-2.
Ishida K; Acharya C; Christiansen BA; Yik JH; DiCesare PE; Haudenschild DR
Bone; 2013 Jul; 55(1):23-35. PubMed ID: 23528838
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R
Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
[TBL] [Abstract][Full Text] [Related]
8. Shedding of a soluble form of BMP receptor-IB controls bone cell responses to BMP.
Singhatanadgit W; Salih V; Olsen I
Bone; 2006 Nov; 39(5):1008-1017. PubMed ID: 16774854
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein receptor in the osteogenic differentiation of rat bone marrow stromal cells.
Wang A; Ding X; Sheng S; Yao Z
Yonsei Med J; 2010 Sep; 51(5):740-5. PubMed ID: 20635450
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells.
Singhatanadgit W; Salih V; Olsen I
Int J Biochem Cell Biol; 2006; 38(10):1794-807. PubMed ID: 16797218
[TBL] [Abstract][Full Text] [Related]
11. Sequential Treatment with SDF-1 and BMP-2 Potentiates Bone Formation in Calvarial Defects.
Hwang HD; Lee JT; Koh JT; Jung HM; Lee HJ; Kwon TG
Tissue Eng Part A; 2015 Jul; 21(13-14):2125-35. PubMed ID: 25919507
[TBL] [Abstract][Full Text] [Related]
12. The immunomodulatory role of sulfated chitosan in BMP-2-mediated bone regeneration.
Shu Y; Yu Y; Zhang S; Wang J; Xiao Y; Liu C
Biomater Sci; 2018 Aug; 6(9):2496-2507. PubMed ID: 30091436
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
[TBL] [Abstract][Full Text] [Related]
14. Effects of Diclofenac Sodium on BMP-induced Inflammation in a Rodent Model.
Ye S; Yim JH; Kim JR; Jang KY; Wang H; Wang JC; Lee KB
Spine (Phila Pa 1976); 2015 Jul; 40(14):E799-807. PubMed ID: 26164161
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells assembled with low-dose BMP-2 in a three-dimensional hybrid construct enhances posterolateral spinal fusion in syngeneic rats.
Hu T; Abbah SA; Toh SY; Wang M; Lam RW; Naidu M; Bhakta G; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK
Spine J; 2015 Dec; 15(12):2552-63. PubMed ID: 26342750
[TBL] [Abstract][Full Text] [Related]
16. Quinoline compound KM11073 enhances BMP-2-dependent osteogenic differentiation of C2C12 cells via activation of p38 signaling and exhibits in vivo bone forming activity.
Baek SH; Choi SW; Park SJ; Lee SH; Chun HS; Kim SH
PLoS One; 2015; 10(3):e0120150. PubMed ID: 25789987
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
Koide M; Murase Y; Yamato K; Noguchi T; Okahashi N; Nishihara T
Biochem Biophys Res Commun; 1999 May; 259(1):97-102. PubMed ID: 10334922
[TBL] [Abstract][Full Text] [Related]
18. Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study.
Alam S; Ueki K; Nakagawa K; Marukawa K; Hashiba Y; Yamamoto E; Sakulsak N; Iseki S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):22-9. PubMed ID: 18755616
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro.
Fong D; Bisson M; Laberge G; McManus S; Grenier G; Faucheux N; Roux S
Cell Signal; 2013 Apr; 25(4):717-28. PubMed ID: 23313128
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
